Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-11-08
DOI
10.3389/fphar.2016.00422
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice
- (2016) Andreza B. Sonego et al. BEHAVIOURAL BRAIN RESEARCH
- The Impact of Exposure to Cannabinoids in Adolescence: Insights From Animal Models
- (2016) Tiziana Rubino et al. BIOLOGICAL PSYCHIATRY
- Human Laboratory Studies on Cannabinoids and Psychosis
- (2016) Mohamed Sherif et al. BIOLOGICAL PSYCHIATRY
- Therapeutic Potential of Cannabinoids in Psychosis
- (2016) F. Markus Leweke et al. BIOLOGICAL PSYCHIATRY
- Association Between Cannabis and Psychosis: Epidemiologic Evidence
- (2016) Suzanne H. Gage et al. BIOLOGICAL PSYCHIATRY
- An Introduction to the Endogenous Cannabinoid System
- (2016) Hui-Chen Lu et al. BIOLOGICAL PSYCHIATRY
- The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats
- (2016) Cathrin Rohleder et al. Frontiers in Behavioral Neuroscience
- MK-801-induced deficits in social recognition in rats
- (2015) Serena Deiana et al. BEHAVIOURAL PHARMACOLOGY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice
- (2015) Felipe V. Gomes et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The endocannabinoid system in guarding against fear, anxiety and stress
- (2015) Beat Lutz et al. NATURE REVIEWS NEUROSCIENCE
- Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications
- (2015) Ashwini Rajasekaran et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Inflammation in schizophrenia: A question of balance
- (2015) Juan C. Leza et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine
- (2015) J. F. C. Pedrazzi et al. PSYCHOPHARMACOLOGY
- Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
- (2015) Felipe V. Gomes et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia
- (2015) René S. Kahn et al. Nature Reviews Disease Primers
- Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability
- (2014) Fabio Arturo Iannotti et al. ACS Chemical Neuroscience
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons
- (2014) Robert B. Laprairie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabinoid 1 and Transient Receptor Potential Vanilloid 1 Receptors Discretely Modulate Evoked Glutamate Separately from Spontaneous Glutamate Transmission
- (2014) J. A. Fawley et al. JOURNAL OF NEUROSCIENCE
- Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
- (2014) Valéria Almeida et al. SCHIZOPHRENIA RESEARCH
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- (2014) Raquel Levin et al. Frontiers in Pharmacology
- Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol
- (2013) M Jerry Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice
- (2013) K.A. Newell et al. NEUROSCIENCE
- Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice
- (2013) Felipe V. Gomes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users
- (2013) M. Di Forti et al. SCHIZOPHRENIA BULLETIN
- NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
- (2013) Melissa A. Snyder et al. Frontiers in Cellular Neuroscience
- Anandamide Dysfunction in Prodromal and Established Psychosis
- (2012) F. Markus Leweke CURRENT PHARMACEUTICAL DESIGN
- A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
- (2012) Aitor G. Granja et al. Journal of Neuroimmune Pharmacology
- Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague–Dawley rats
- (2012) Anand Gururajan et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
- (2012) Leonora E. Long et al. PLoS One
- Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
- (2012) Valéria Almeida et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats
- (2011) Mariana Bendlin Calzavara et al. BEHAVIOURAL BRAIN RESEARCH
- Effect of cannabidiol in a MK-801-rodent model of aspects of Schizophrenia
- (2011) Anand Gururajan et al. BEHAVIOURAL BRAIN RESEARCH
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fatty Acid-binding Proteins TransportN-Acylethanolamines to Nuclear Receptors and Are Targets of Endocannabinoid Transport Inhibitors
- (2011) Martin Kaczocha et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A catalytically silent FAAH-1 variant drives anandamide transport in neurons
- (2011) Jin Fu et al. NATURE NEUROSCIENCE
- Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine
- (2011) Raquel Levin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- The environment and susceptibility to schizophrenia
- (2010) Alan S. Brown PROGRESS IN NEUROBIOLOGY
- Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
- (2010) Jaime E. C. Hallak et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Assessment of Pharmacotherapy for Negative Symptoms of Schizophrenia
- (2010) Elizabeth Hanson et al. Current Psychiatry Reports
- Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol
- (2009) Sagnik Bhattacharyya et al. ARCHIVES OF GENERAL PSYCHIATRY
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
- (2009) Paolo Fusar-Poli et al. ARCHIVES OF GENERAL PSYCHIATRY
- Voluntary physical exercise alters attentional orienting and social behavior in a rat model of attention-deficit/hyperactivity disorder.
- (2009) Michael E. Hopkins et al. BEHAVIORAL NEUROSCIENCE
- High-potency cannabis and the risk of psychosis
- (2009) Marta Di Forti et al. BRITISH JOURNAL OF PSYCHIATRY
- Time-dependent vascular actions of cannabidiol in the rat aorta
- (2009) Saoirse E. O'Sullivan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
- (2009) Leonora E. Long et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia
- (2009) Glenn Schwarcz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
- (2009) N. A. Jones et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats
- (2009) Daniel Thomas Malone et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Identification of intracellular carriers for the endocannabinoid anandamide
- (2009) M. Kaczocha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The endocannabinoid system as a target for modelling psychosis
- (2009) Dagmar Koethe et al. PSYCHOPHARMACOLOGY
- Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis
- (2008) O. Mason et al. PSYCHOLOGICAL MEDICINE
- Neuroleptic Drugs Revert the Contextual Fear Conditioning Deficit Presented by Spontaneously Hypertensive Rats: A Potential Animal Model of Emotional Context Processing in Schizophrenia?
- (2008) M. B. Calzavara et al. SCHIZOPHRENIA BULLETIN
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More